4//SEC Filing
RIPLEY DANIEL L. 4
Accession 0001209191-18-007561
CIK 0001383701other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:02 PM ET
Size
10.4 KB
Accession
0001209191-18-007561
Insider Transaction Report
Form 4
RIPLEY DANIEL L.
SVP, Bus Dev, P&A Mgmt
Transactions
- Award
Common Stock
2017-05-12$1.70/sh+761$1,294→ 28,462 total(indirect: See footnote.) - Award
Common Stock
2017-11-14$3.48/sh+818$2,847→ 29,280 total(indirect: See footnote.) - Award
Stock Option (Right to Buy)
2018-02-04+40,000→ 40,000 totalExercise: $5.17Exp: 2028-02-03→ Common Stock (40,000 underlying)
Footnotes (5)
- [F1]These shares were acquired under the Company's 2013 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]In accordance with the Company's 2013 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2016, which was the first trading day of the applicable offering period.
- [F3]Held by family trust of which the Reporting Person is a trustee. Shares transferred from Reporting Person to family trust immediately following acquisition.
- [F4]In accordance with the Company's 2013 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 14, 2017, which was the last trading day of the applicable offering period.
- [F5]The option was granted on February 4, 2018. 25% of the total number of shares of common stock subject to the option will vest on February 2, 2019, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001696981
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:02 PM ET
- Size
- 10.4 KB